Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 17 |
GO:0110165 | cellular anatomical entity | 1 | 17 |
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0005794 | Golgi apparatus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Related structures:
AlphaFold database: A0A3S5H6J6
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 2 |
GO:0006605 | protein targeting | 5 | 2 |
GO:0006612 | protein targeting to membrane | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006897 | endocytosis | 5 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018198 | peptidyl-cysteine modification | 6 | 2 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 2 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 2 |
GO:0018345 | protein palmitoylation | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043543 | protein acylation | 5 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0051668 | localization within membrane | 3 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0072657 | protein localization to membrane | 4 | 2 |
GO:0090150 | establishment of protein localization to membrane | 4 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 17 |
GO:0016409 | palmitoyltransferase activity | 5 | 17 |
GO:0016417 | S-acyltransferase activity | 5 | 17 |
GO:0016740 | transferase activity | 2 | 17 |
GO:0016746 | acyltransferase activity | 3 | 17 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 17 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 17 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 17 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 17 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 185 | 189 | PF00656 | 0.487 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.252 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.395 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.279 |
CLV_PCSK_FUR_1 | 91 | 95 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.259 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.328 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.279 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.326 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.573 |
DOC_MAPK_MEF2A_6 | 259 | 267 | PF00069 | 0.322 |
DOC_PP2B_LxvP_1 | 38 | 41 | PF13499 | 0.590 |
DOC_PP4_FxxP_1 | 306 | 309 | PF00568 | 0.510 |
DOC_PP4_FxxP_1 | 97 | 100 | PF00568 | 0.485 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.595 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.659 |
DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.698 |
DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.582 |
DOC_USP7_UBL2_3 | 193 | 197 | PF12436 | 0.461 |
LIG_14-3-3_CanoR_1 | 291 | 296 | PF00244 | 0.449 |
LIG_14-3-3_CanoR_1 | 99 | 105 | PF00244 | 0.479 |
LIG_Actin_WH2_2 | 277 | 293 | PF00022 | 0.369 |
LIG_BIR_III_4 | 45 | 49 | PF00653 | 0.597 |
LIG_BRCT_BRCA1_1 | 120 | 124 | PF00533 | 0.351 |
LIG_BRCT_BRCA1_1 | 145 | 149 | PF00533 | 0.319 |
LIG_BRCT_BRCA1_1 | 254 | 258 | PF00533 | 0.287 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.516 |
LIG_FHA_2 | 183 | 189 | PF00498 | 0.490 |
LIG_LIR_Apic_2 | 303 | 309 | PF02991 | 0.497 |
LIG_LIR_Gen_1 | 216 | 225 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 228 | 236 | PF02991 | 0.300 |
LIG_LIR_Gen_1 | 292 | 299 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 121 | 127 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 228 | 233 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 292 | 298 | PF02991 | 0.478 |
LIG_MLH1_MIPbox_1 | 254 | 258 | PF16413 | 0.287 |
LIG_PCNA_yPIPBox_3 | 135 | 143 | PF02747 | 0.200 |
LIG_Pex14_1 | 120 | 124 | PF04695 | 0.253 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.211 |
LIG_Pex14_2 | 161 | 165 | PF04695 | 0.523 |
LIG_SH2_CRK | 111 | 115 | PF00017 | 0.366 |
LIG_SH2_PTP2 | 127 | 130 | PF00017 | 0.369 |
LIG_SH2_SRC | 104 | 107 | PF00017 | 0.542 |
LIG_SH2_SRC | 295 | 298 | PF00017 | 0.516 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.264 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.248 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.444 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.611 |
LIG_SUMO_SIM_par_1 | 50 | 55 | PF11976 | 0.578 |
LIG_TRAF2_1 | 309 | 312 | PF00917 | 0.500 |
LIG_TYR_ITSM | 291 | 298 | PF00017 | 0.400 |
LIG_WRC_WIRS_1 | 230 | 235 | PF05994 | 0.225 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.664 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.308 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.667 |
MOD_Cter_Amidation | 299 | 302 | PF01082 | 0.276 |
MOD_GlcNHglycan | 10 | 15 | PF01048 | 0.436 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.317 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.330 |
MOD_GlcNHglycan | 24 | 28 | PF01048 | 0.353 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.400 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.535 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.383 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.521 |
MOD_N-GLC_2 | 196 | 198 | PF02516 | 0.249 |
MOD_N-GLC_2 | 210 | 212 | PF02516 | 0.229 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.275 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.571 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.709 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.440 |
MOD_NEK2_2 | 144 | 149 | PF00069 | 0.211 |
MOD_PIKK_1 | 129 | 135 | PF00454 | 0.446 |
MOD_PKA_1 | 182 | 188 | PF00069 | 0.503 |
MOD_PKA_1 | 316 | 322 | PF00069 | 0.504 |
MOD_PKA_2 | 182 | 188 | PF00069 | 0.461 |
MOD_PKA_2 | 252 | 258 | PF00069 | 0.196 |
MOD_PKA_2 | 290 | 296 | PF00069 | 0.471 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.578 |
MOD_Plk_1 | 302 | 308 | PF00069 | 0.513 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.294 |
MOD_Plk_4 | 144 | 150 | PF00069 | 0.362 |
MOD_Plk_4 | 225 | 231 | PF00069 | 0.348 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.472 |
TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.351 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.224 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.534 |
TRG_ENDOCYTIC_2 | 218 | 221 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 295 | 298 | PF00928 | 0.417 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.441 |
TRG_ER_diArg_1 | 81 | 83 | PF00400 | 0.576 |
TRG_ER_diArg_1 | 91 | 94 | PF00400 | 0.506 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3T7 | Leptomonas seymouri | 31% | 79% |
A0A0N1I382 | Leptomonas seymouri | 49% | 80% |
A0A1X0NUX2 | Trypanosomatidae | 30% | 88% |
A0A3R7RC91 | Trypanosoma rangeli | 30% | 96% |
A0A3S7WX91 | Leishmania donovani | 31% | 82% |
A4H6N3 | Leishmania braziliensis | 68% | 100% |
A4HCH5 | Leishmania braziliensis | 31% | 81% |
A4HV17 | Leishmania infantum | 100% | 100% |
C9ZSP6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 90% |
E9AH03 | Leishmania infantum | 31% | 82% |
E9ANQ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9AVW7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 81% |
Q06551 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 90% |
Q4QBL2 | Leishmania major | 31% | 82% |
Q4QGX1 | Leishmania major | 91% | 96% |
Q750R7 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 26% | 88% |
Q8R0N9 | Mus musculus | 29% | 67% |
Q8WTX9 | Homo sapiens | 27% | 67% |
V5B8P9 | Trypanosoma cruzi | 31% | 93% |
V5BWI0 | Trypanosoma cruzi | 44% | 94% |